Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$1.11
-4.4%
$1.22
$0.84
$2.03
$42.29M0.99118,475 shs122,306 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$20.86
C$18.60
C$22.79
N/AN/A468,009 shs3.04 million shs
IDACORP, Inc. stock logo
IDA
IDACORP
$94.60
-0.1%
$90.63
$86.43
$112.91
$4.80B0.56379,557 shs434,452 shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-2.52%+1.75%-2.52%+6.42%-28.40%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
First Capital Realty Inc. stock logo
FCR
First Capital Realty
0.00%0.00%0.00%0.00%0.00%
IDACORP, Inc. stock logo
IDA
IDACORP
+0.35%+2.61%+4.63%+2.26%-14.67%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
2.0984 of 5 stars
3.50.00.00.01.63.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/AN/AN/A
IDACORP, Inc. stock logo
IDA
IDACORP
3.8056 of 5 stars
1.03.05.03.01.91.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3.00
Buy$7.00531.20% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/A
IDACORP, Inc. stock logo
IDA
IDACORP
2.00
Hold$93.80-0.85% Downside

Current Analyst Ratings

Latest IDA, BOLT, CZX, and FCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
3/21/2024
IDACORP, Inc. stock logo
IDA
IDACORP
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$92.00 ➝ $95.00
3/13/2024
IDACORP, Inc. stock logo
IDA
IDACORP
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$92.00
3/5/2024
IDACORP, Inc. stock logo
IDA
IDACORP
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$99.00 ➝ $88.00
2/16/2024
IDACORP, Inc. stock logo
IDA
IDACORP
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$100.00 ➝ $94.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M5.37N/AN/A$2.97 per share0.37
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/A
IDACORP, Inc. stock logo
IDA
IDACORP
$1.77B2.71$9.14 per share10.35$57.59 per share1.64

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.83N/AN/AN/A-878.58%-51.18%-37.81%5/9/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/A0.00N/AN/AN/AN/AN/A5/1/2024 (Confirmed)
IDACORP, Inc. stock logo
IDA
IDACORP
$261.20M$5.1418.4016.71N/A14.79%9.06%3.22%5/2/2024 (Confirmed)

Latest IDA, BOLT, CZX, and FCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
IDACORP, Inc. stock logo
IDA
IDACORP
$1.01N/A-$1.01N/AN/AN/A  
5/1/2024N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.29N/A-C$0.29N/AN/AN/A
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million
2/15/2024Q4 2023
IDACORP, Inc. stock logo
IDA
IDACORP
$0.60$0.61+$0.01$0.61$429.84 million$411.95 million      
2/6/2024Q4 2023
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.31C$0.81+C$0.50C$0.81N/AC$171.18 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/A
IDACORP, Inc. stock logo
IDA
IDACORP
$3.323.51%+5.57%64.59%12 Years

Latest IDA, BOLT, CZX, and FCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/18/2024
IDACORP, Inc. stock logo
IDA
IDACORP
Quarterly$0.833.54%5/3/20245/6/20245/30/2024
4/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.074.14%4/29/20244/30/20245/15/2024
3/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.073/27/20243/28/20244/15/2024
2/6/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.072/28/20242/29/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.15
5.17
5.17
CZX
Canada Zinc Metals
N/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/A
IDACORP, Inc. stock logo
IDA
IDACORP
0.95
1.58
1.33

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
IDACORP, Inc. stock logo
IDA
IDACORP
89.10%

Insider Ownership

CompanyInsider Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
28.40%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
IDACORP, Inc. stock logo
IDA
IDACORP
0.47%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million27.30 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/ANot Optionable
IDACORP, Inc. stock logo
IDA
IDACORP
2,11250.69 million50.46 millionOptionable

IDA, BOLT, CZX, and FCR Headlines

SourceHeadline
IDACORP (IDA) Scheduled to Post Quarterly Earnings on ThursdayIDACORP (IDA) Scheduled to Post Quarterly Earnings on Thursday
americanbankingnews.com - April 25 at 4:46 AM
IDACORP Schedules First Quarter 2024 Earnings Release & Conference CallIDACORP Schedules First Quarter 2024 Earnings Release & Conference Call
businesswire.com - April 22 at 10:58 AM
Louisiana State Employees Retirement System Purchases New Holdings in IDACORP, Inc. (NYSE:IDA)Louisiana State Employees Retirement System Purchases New Holdings in IDACORP, Inc. (NYSE:IDA)
marketbeat.com - April 22 at 5:12 AM
IDACORP, Inc. (NYSE:IDA) to Issue $0.83 Quarterly DividendIDACORP, Inc. (NYSE:IDA) to Issue $0.83 Quarterly Dividend
marketbeat.com - April 20 at 9:14 AM
IDACORP, Inc. Declares DividendIDACORP, Inc. Declares Dividend
businesswire.com - April 18 at 4:55 PM
Mutual of America Capital Management LLC Has $3.46 Million Position in IDACORP, Inc. (NYSE:IDA)Mutual of America Capital Management LLC Has $3.46 Million Position in IDACORP, Inc. (NYSE:IDA)
marketbeat.com - April 18 at 5:31 AM
River Road Asset Management LLC Sells 30,977 Shares of IDACORP, Inc. (NYSE:IDA)River Road Asset Management LLC Sells 30,977 Shares of IDACORP, Inc. (NYSE:IDA)
marketbeat.com - April 17 at 4:41 PM
East Bank Master Developer Agreement with The Fallon Company ApprovedEast Bank Master Developer Agreement with The Fallon Company Approved
businesswire.com - April 17 at 1:15 PM
Allspring Global Investments Holdings LLC Buys 105,272 Shares of IDACORP, Inc. (NYSE:IDA)Allspring Global Investments Holdings LLC Buys 105,272 Shares of IDACORP, Inc. (NYSE:IDA)
marketbeat.com - April 14 at 5:44 AM
Ceredex Value Advisors LLC Takes $16.76 Million Position in IDACORP, Inc. (NYSE:IDA)Ceredex Value Advisors LLC Takes $16.76 Million Position in IDACORP, Inc. (NYSE:IDA)
marketbeat.com - April 8 at 8:17 AM
IDACORPs (NYSE:IDA) Returns Have Hit A WallIDACORP's (NYSE:IDA) Returns Have Hit A Wall
finance.yahoo.com - April 1 at 8:27 AM
IDACORP, Inc. (NYSE:IDA) Sees Large Increase in Short InterestIDACORP, Inc. (NYSE:IDA) Sees Large Increase in Short Interest
marketbeat.com - March 31 at 1:42 PM
Raymond James & Associates Sells 22,531 Shares of IDACORP, Inc. (NYSE:IDA)Raymond James & Associates Sells 22,531 Shares of IDACORP, Inc. (NYSE:IDA)
marketbeat.com - March 30 at 4:33 AM
Is IDACORP, Inc.s (NYSE:IDA) Recent Performance Underpinned By Weak Financials?Is IDACORP, Inc.'s (NYSE:IDA) Recent Performance Underpinned By Weak Financials?
finance.yahoo.com - March 11 at 9:17 AM
Mizuho Maintains Neutral Rating for Idacorp: Heres What You Need To KnowMizuho Maintains Neutral Rating for Idacorp: Here's What You Need To Know
markets.businessinsider.com - March 6 at 6:53 PM
Idacorp: An Underfollowed Utility Worth Buying NowIdacorp: An Underfollowed Utility Worth Buying Now
seekingalpha.com - February 25 at 7:30 AM
Southern (SO) Q4 Earnings Beat on Lower Costs, Sales MissSouthern (SO) Q4 Earnings Beat on Lower Costs, Sales Miss
finance.yahoo.com - February 19 at 1:46 PM
IDACORP, Inc. (NYSE:IDA) Annual Results Just Came Out: Heres What Analysts Are Forecasting For This YearIDACORP, Inc. (NYSE:IDA) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year
finance.yahoo.com - February 18 at 9:54 AM
IDACORP Full Year 2023 Earnings: Revenues Beat Expectations, EPS In LineIDACORP Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
finance.yahoo.com - February 17 at 1:16 PM
Maintaining Hold on IdaCorp Amidst Balanced Capital Expenditure and Earnings OutlookMaintaining Hold on IdaCorp Amidst Balanced Capital Expenditure and Earnings Outlook
markets.businessinsider.com - February 16 at 3:35 PM
IDACORP, Inc. (NYSE:IDA) Q4 2023 Earnings Call TranscriptIDACORP, Inc. (NYSE:IDA) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 16 at 3:35 PM
Q4 2023 Idacorp Inc Earnings CallQ4 2023 Idacorp Inc Earnings Call
finance.yahoo.com - February 16 at 10:28 AM
IDACORPs (IDA) Q4 Earnings Top Estimates, Clean Energy AddedIDACORP's (IDA) Q4 Earnings Top Estimates, Clean Energy Added
msn.com - February 15 at 6:47 PM
IDACORP, Inc. 2023 Q4 - Results - Earnings Call PresentationIDACORP, Inc. 2023 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 15 at 4:56 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
First Capital Realty logo

First Capital Realty

TSE:FCR
IDACORP logo

IDACORP

NYSE:IDA
IDACORP, Inc., together with its subsidiaries, engages in the generation, transmission, distribution, purchase, and sale of electric energy in the United States. The company operates 17 hydropower generating plants located in southern Idaho and eastern Oregon; three natural gas-fired plants in southern Idaho; and interests in two coal-fired steam electric generating plants located in Wyoming and Nevada. As of December 31, 2023, it had approximately 4,762 pole-miles of high-voltage transmission lines; 23 step-up transmission substations located at power plants; 21 transmission substations; 11 switching stations; 30 mixed-use transmission and distribution substations; 186 energized distribution substations; and 29,714 pole-miles of distribution lines, and 131 MW of battery storage, as well as provides electric utility services to approximately 633,000 retail customers in southern Idaho and eastern Oregon. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education. It also invests in housing and other real estate tax credit investments. IDACORP, Inc. was founded in 1915 and is headquartered in Boise, Idaho.